Next Article in Journal
Clavine Alkaloids Gene Clusters of Penicillium and Related Fungi: Evolutionary Combination of Prenyltransferases, Monooxygenases and Dioxygenases
Previous Article in Journal
Connections between Transcription Downstream of Genes and cis-SAGe Chimeric RNA
Previous Article in Special Issue
RNA Pseudouridylation in Physiology and Medicine: For Better and for Worse
Review

Role of Non-Coding RNAs in the Etiology of Bladder Cancer

1
Department of Gynecology, Obstetrics and Urology, Policlinico Umberto I, Sapienza University of Rome, 00161 Rome, Italy
2
Department of Obstetrics and Gynaecology, Misericordia Hospital, 58100 Grosseto, Italy
3
Department of Obstetrics and Gynaecology, Azienda Ospedaliera San Camillo-Forlanini, 00152 Rome, Italy
4
Department of Urology, Misericordia Hospital, 58100 Grosseto, Italy
5
Pediatric Surgery and Urology Unit, Azienda Ospedaliera San Camillo-Forlanini, 00152 Rome, Italy
6
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
7
Institute of Molecular Biology and Pathology, Italian National Research Council (CNR-IBPM), 00185 Rome, Italy
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Received: 27 August 2017 / Revised: 3 November 2017 / Accepted: 7 November 2017 / Published: 22 November 2017
(This article belongs to the Special Issue RNA Modification)
According to data of the International Agency for Research on Cancer and the World Health Organization (Cancer Incidence in Five Continents, GLOBOCAN, and the World Health Organization Mortality), bladder is among the top ten body locations of cancer globally, with the highest incidence rates reported in Southern and Western Europe, North America, Northern Africa and Western Asia. Males (M) are more vulnerable to this disease than females (F), despite ample frequency variations in different countries, with a M:F ratio of 4.1:1 for incidence and 3.6:1 for mortality, worldwide. For a long time, bladder cancer was genetically classified through mutations of two genes, fibroblast growth factor receptor 3 (FGFR3, for low-grade, non-invasive papillary tumors) and tumor protein P53 (TP53, for high-grade, muscle-invasive tumors). However, more recently scientists have shown that this disease is far more complex, since genes directly involved are more than 150; so far, it has been described that altered gene expression (up- or down-regulation) may be present for up to 500 coding sequences in low-grade and up to 2300 in high-grade tumors. Non-coding RNAs are essential to explain, at least partially, this ample dysregulation. In this review, we summarize the present knowledge about long and short non-coding RNAs that have been linked to bladder cancer etiology. View Full-Text
Keywords: TP53; FGFR3; microRNA; small non-coding RNA; long non-coding RNA; epigenetics TP53; FGFR3; microRNA; small non-coding RNA; long non-coding RNA; epigenetics
Show Figures

Figure 1

MDPI and ACS Style

Gulìa, C.; Baldassarra, S.; Signore, F.; Rigon, G.; Pizzuti, V.; Gaffi, M.; Briganti, V.; Porrello, A.; Piergentili, R. Role of Non-Coding RNAs in the Etiology of Bladder Cancer. Genes 2017, 8, 339. https://0-doi-org.brum.beds.ac.uk/10.3390/genes8110339

AMA Style

Gulìa C, Baldassarra S, Signore F, Rigon G, Pizzuti V, Gaffi M, Briganti V, Porrello A, Piergentili R. Role of Non-Coding RNAs in the Etiology of Bladder Cancer. Genes. 2017; 8(11):339. https://0-doi-org.brum.beds.ac.uk/10.3390/genes8110339

Chicago/Turabian Style

Gulìa, Caterina, Stefano Baldassarra, Fabrizio Signore, Giuliano Rigon, Valerio Pizzuti, Marco Gaffi, Vito Briganti, Alessandro Porrello, and Roberto Piergentili. 2017. "Role of Non-Coding RNAs in the Etiology of Bladder Cancer" Genes 8, no. 11: 339. https://0-doi-org.brum.beds.ac.uk/10.3390/genes8110339

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop